Target
Herceptin
1 abstract
Abstract
Heterogeneity of immune status in patient-derived malignant pleural effusion and ascites: Relationship to the ex-vivo efficacy of a HER2-targeted tri-specific antibody and a novel cytokine fusion protein.Org: Nanjing JSIAMA Biopharmaceuticals Ltd, Nanjing JSIAMA Biopharmaceuticals Ltd., K2 Oncology Co. Ltd.,